Skip to main content

Mindfulness clinical trials at UCSD

2 in progress, 1 open to eligible people

Showing trials for
  • Mindfulness Engaged Neurostimulation for Depression

    open to eligible people ages 18-60

    Repetitive Transcranial Magnetic stimulation (rTMS) is an FDA-approved therapy for treatment resistant depression (TRD) that involves brief magnetic stimulation pulses on the dorsolateral prefrontal cortex (DLPFC) brain region. But studies of rTMS alone show remission rates of ~30%. Additionally, rTMS has not been shown to improve cognitive functioning that may be an independent factor predicting treatment success. This study will develop a novel multimodal treatment, which combines intermittent theta burst stimulation (iTBS) - a type of rTMS with digital mindfulness training to engage brain plasticity, enhance cognition and alleviate depression symptoms in individuals with TRD.

    La Jolla, California

  • Mindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal Study

    Sorry, in progress, not accepting new patients

    To investigate the efficacy of Mindfulness-based Stress Reduction (MBSR),to improve HRQoL, cognition, and mood, as well as to determine the longevity of the treatment response in individuals with Parkinson's disease (PD).

    San Diego, California

Our lead scientists for Mindfulness research studies include .

Last updated: